National Health Investors, Inc. (NHI) To Go Ex-Dividend on March 27th

National Health Investors, Inc. (NYSE:NHIGet Free Report) declared a quarterly dividend on Tuesday, February 20th, Zacks reports. Investors of record on Thursday, March 28th will be given a dividend of 0.90 per share by the real estate investment trust on Friday, May 3rd. This represents a $3.60 annualized dividend and a yield of 5.87%. The ex-dividend date of this dividend is Wednesday, March 27th.

National Health Investors has decreased its dividend by an average of 6.5% per year over the last three years. National Health Investors has a dividend payout ratio of 119.6% indicating that the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Equities analysts expect National Health Investors to earn $4.55 per share next year, which means the company should continue to be able to cover its $3.60 annual dividend with an expected future payout ratio of 79.1%.

National Health Investors Stock Performance

Shares of NYSE:NHI opened at $61.30 on Monday. The firm’s 50 day simple moving average is $56.23 and its 200-day simple moving average is $54.02. The company has a debt-to-equity ratio of 0.90, a quick ratio of 10.27 and a current ratio of 10.27. National Health Investors has a one year low of $47.54 and a one year high of $62.30. The firm has a market cap of $2.66 billion, a PE ratio of 19.58 and a beta of 0.94.

Analyst Ratings Changes

NHI has been the subject of several research reports. BMO Capital Markets upgraded National Health Investors from a “market perform” rating to an “outperform” rating and set a $67.00 target price for the company in a report on Tuesday, March 12th. Wedbush increased their target price on shares of National Health Investors from $64.00 to $66.00 and gave the stock an “outperform” rating in a report on Monday, March 18th. Wells Fargo & Company upgraded shares of National Health Investors from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $55.00 to $63.00 in a report on Monday, February 26th. Deutsche Bank Aktiengesellschaft started coverage on shares of National Health Investors in a research note on Tuesday, January 30th. They set a “buy” rating and a $69.00 price objective on the stock. Finally, Stifel Nicolaus reiterated a “hold” rating and issued a $55.00 price target on shares of National Health Investors in a report on Tuesday, November 28th. Five investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, National Health Investors currently has a consensus rating of “Hold” and a consensus target price of $59.22.

Read Our Latest Research Report on NHI

Insider Transactions at National Health Investors

In other National Health Investors news, Director Charlotte A. Swafford purchased 10,000 shares of the stock in a transaction on Tuesday, February 27th. The shares were bought at an average cost of $58.69 per share, with a total value of $586,900.00. Following the completion of the acquisition, the director now owns 110,185 shares in the company, valued at $6,466,757.65. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 8.21% of the company’s stock.

Institutional Investors Weigh In On National Health Investors

Several hedge funds have recently bought and sold shares of the stock. Lazard Asset Management LLC acquired a new position in shares of National Health Investors in the second quarter worth about $32,000. Advisory Services Network LLC boosted its position in National Health Investors by 71.8% during the first quarter. Advisory Services Network LLC now owns 737 shares of the real estate investment trust’s stock worth $38,000 after purchasing an additional 308 shares in the last quarter. KBC Group NV acquired a new stake in National Health Investors in the fourth quarter valued at approximately $50,000. State of Wyoming increased its position in shares of National Health Investors by 199.3% in the fourth quarter. State of Wyoming now owns 1,242 shares of the real estate investment trust’s stock valued at $65,000 after buying an additional 827 shares in the last quarter. Finally, Captrust Financial Advisors acquired a new position in shares of National Health Investors during the 2nd quarter worth approximately $116,000. Hedge funds and other institutional investors own 62.51% of the company’s stock.

About National Health Investors

(Get Free Report)

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

Featured Articles

Dividend History for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with's FREE daily email newsletter.